Krystal Biotech
Organization
Trials
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Phase 1/2, Recruiting, 250 people, Jan 29, 2024
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
Phase 1/2, Recruiting, 240 people, Aug 1, 2023
Sources: clinicaltrials.gov